Investment In Parkinson’s Disease Data Bank Yields Potential Therapy
October 13, 2009 by
Filed under Supplements
Individuals with Parkinson’s disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health. A clinical trial is under way to examine the safety and potential benefits of supplemental urate elevation for recently diagnosed Parkinson’s patients who have low urate levels.
Go here to read the rest:
Investment In Parkinson’s Disease Data Bank Yields Potential Therapy